[Retracted] mRNA-Modified FUS/NRF2 Signalling Inhibits Ferroptosis and Promotes Prostate Cancer Growth

Figure 4

Effects of Erastin and ferroptosis inhibitor treatment on CRPC cell viability and FUS expression. (a) Cell viability of LNCaP cells after treatment. (b) Cell viability of C42 cells after treatment. (c) FUS expression of LNCaP cells after treatment. (d) FUS expression in C42 cells after treatment.

(a)

(b)

(c)

(d)